High-Dose Intravenous Lipid for Very Preterm or Very Low Birth Weight Infants Effects on Growth
Launched by INDONESIA UNIVERSITY · Mar 27, 2025
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Neonates with \<32 weeks gestation age or \<1500 gram birth weight gets early intravena lipid start with 2 gram per body weight and 1 gram per body weigh then observed the time to reach birth weight
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • birth weight below 1500 gram or gestational age below 32 weeks
- Exclusion Criteria:
- • mayor congenital abnormalities
About Indonesia University
Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jakarta, Central Jakarta, Indonesia
Patients applied
Trial Officials
Putri MT Marsubrin, MD, PhD
Principal Investigator
Cipto Mangunkusumo Hospital, Jakarta, Central Jakarta 10430
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported